DavidJRawlingsMD
Pediatric Rheumatology • Seattle, WAProfessor, Pediatrics, University of Washington School of Medicine
Are you Dr. Rawlings?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 11 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4800 Sand Point Way Ne
Seattle, WA 98105Phone+1 206-987-2000- Is this information wrong?
Summary
- Dr. David Rawlings, MD is a pediatric rheumatologist in Seattle, Washington. He is currently licensed to practice medicine in Washington, Maryland, and California. He is affiliated with Seattle Children's Hospital and is a Professor at University of Washington School of Medicine.
Education & Training
University of North Carolina at Chapel Hill School of MedicineClass of 1984
Certifications & Licensure
CA State Medical License 1986 - Present
WA State Medical License 2001 - 2026
MD State Medical License 1988 - 1991- American Board of Pediatrics Pediatric Rheumatology
Clinical Trials
- Gene Transfer for X-Linked Severe Combined Immunodeficiency in Newly Diagnosed Infants Start of enrollment: 2016 Aug 17
Publications & Presentations
PubMed
- 4 citationsCutting Edge: Systemic Autoimmunity in Murine STAT3 Gain-of-Function Syndrome Is Characterized by Effector T Cell Expansion in the Absence of Overt Regulatory T Cell D...Jonathan Woods, Sarah E Pemberton, Andrea D Largent, Kristy Chiang, Denny Liggitt, Mohamed Oukka, David J Rawlings, Shaun W Jackson> ;Journal of Immunology. 2022 Sep 15
- 3 citationsCRISPR/Cas9-Mediated Insertion of HIV Long Terminal Repeat withinPromotes Expansion of T Regulatory-like Cells.Michelle L Christian, Michael J Dapp, Samuel C Scharffenberger, Hank Jones, Chaozhong Song, Lisa M Frenkel, Anthony Krumm, James I Mullins, David J Rawlings> ;Journal of Immunology. 2022 Apr 1
- 1 citationsTACI haploinsufficiency protects against BAFF-driven humoral autoimmunity in mice.Holly M. Jacobs, Tanvi Arkatkar, Samuel W. Du, Nicole E. Scharping, Jonathan Woods, Quan Zhen Li, Kelly L. Hudkins, Charles E. Alpers, David J. Rawlings, Shaun W. Jackson> ;European Journal of Immunology. 2021 Jun 27
- Join now to see all
Press Mentions
- Emendo Biotherapeutics and Seattle Children’s Research Institute Announce Collaboration to Develop CRISPR-Based Therapeutic Strategy for Severe Congenital NeutropeniaDecember 22nd, 2021
- Seattle Children’s Research Division: Celebrating 15 Years of InnovationNovember 12th, 2021
Seattle Children’s Licenses Gene-Editing Therapy to Casebia Therapeutics and Will Partner on Further ResearchSeptember 27th, 2017
Hospital Affiliations
Seattle Children's HospitalSeattle, Washington
